Eterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics

8M ago

ERNA

More ERNA News >

ERNA News on the Web

2024-03-22

Eterna Therapeutics faces Nasdaq noncompliance issue

Investing.com

Neutral

2024-03-15

ISRG Stock Alert: The FDA Is Giving Intuitive Surgical a Big Boost

InvestorPlace

Neutral

2024-03-15

ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q4 2023

InvestorPlace

Neutral

2024-02-20

Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors

Yahoo Finance

Bullish

2024-01-03

Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635

Yahoo Finance

Neutral

2023-12-21

Eterna Therapeutics Appoints Sanjeev Luther as President and CEO

Yahoo Finance

Neutral

2023-12-20

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer

Yahoo Finance

Neutral

2023-12-14

Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing

Yahoo Finance

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ERNA’s Media Buzz Sentiment?

Currently, no data Available

What is ERNA’s weekly average amount of articles?

Currently, no data Available

What is ERNA’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

RMDResmed

AMEDAmedisys

MORFMorphic Holding

NBIXNeurocrine

TAKTakeda Pharmaceutical Company

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing